Warsaw Breakage Syndrome
WABS

Contact us
 
Return to database


We were unfortunately unable to download the information for this disease from OMIM.



Prevalence of clinical parameters (%)







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Short stature skeletal 100 % 23033317 2014-04-10
Mental retardation nervous 100 % 23033317 2014-04-10
Microcephaly nervous 100 % 23033317 2014-04-10
Hearing loss due to Cochlear malformation skeletal 100 % 23033317 2014-04-10
Prominent nose skeletal 100 % 23033317 2014-04-10
Prominent ears integumentary 100 % 23033317 2014-04-10
Clinodactyly skeletal 50 % 23033317 2014-04-10
Syndactyly skeletal 25 % 23033317 2014-04-10
Ventricular septal defects circulatory 25 % 23033317 2014-04-10
Tetralogy of Fallot nervous 25 % 23033317 2014-04-10



List of references:


Identification and biochemical characterization of a novel mutation in DDX11 causing Warsaw breakage syndrome.
José-Mario Capo-Chichi, Sanjay Kumar Bharti, Joshua A Sommers, Tony Yammine, Eliane Chouery, Lysanne Patry, Guy A Rouleau, Mark E Samuels, Fadi F Hamdan, Jacques L Michaud, Robert M Brosh, André Mégarbane, Zoha Kibar,

Mutations in the gene encoding the iron-sulfur-containing DNA helicase DDX11 (ChlR1) were recently identified as a cause of a new recessive cohesinopathy, Warsaw breakage syndrome (WABS), in a single patient with severe microcephaly, pre- and postnatal growth retardation, and abnormal skin pigmentation. Here, using homozygosity mapping in a Lebanese consanguineous family followed by exome sequencing, we identified a novel homozygous mutation (c.788G>A [p.R263Q]) in DDX11 in three affected siblings with severe intellectual disability and many of the congenital abnormalities reported in the WABS original case. Cultured lymphocytes from the patients showed increased mitomycin C-induced chromosomal breakage, as found in WABS. Biochemical studies of purified recombinant DDX11 indicated that the p.R263Q mutation impaired DDX11 helicase activity by perturbing its DNA binding and DNA-dependent ATP hydrolysis. Our findings thus confirm the involvement of DDX11 in WABS, describe its phenotypical spectrum, and provide novel insight into the structural requirement for DDX11 activity.

Human mutation - Jan 2013